How do I find out if I qualify for a refractory b-cell non-hodgkin lymphoma study in California?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in California to take part?

Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a refractory b-cell non-hodgkin lymphoma trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · California

Refractory B-Cell Non-Hodgkin Lymphoma clinical trials in California

We’re tracking 28 recruiting refractory b-cell non-hodgkin lymphoma studies with a site in California — including Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.

Recruiting studies in California

NCT06905509RecruitingPhase 2
Epcoritamab with chemo and stem cell transplant for large B-cell lymphoma
This trial tests adding epcoritamab (an immune therapy that helps your body fight cancer) to standard chemotherapy followed by a stem cell transplant. It is for people with large B-cell lymphoma that has come back or not responded to initial treatment.
Sacramento, CaliforniaAges 18 years+
NCT07439653RecruitingPhase 1/Phase 2
Testing TORL-5-700 for advanced lymphoma
This trial tests a new treatment called TORL-5-700 for people with certain types of non-Hodgkin lymphoma that have not responded to other treatments. The goal is to see how safe it is and how well it works.
Fullerton, CaliforniaAges 18 years+
NCT07123454RecruitingPhase 1/Phase 2
Study of AZD4512 for relapsed or refractory B-cell lymphoma
This trial tests a new drug called AZD4512, alone or with other cancer treatments, for people whose B-cell non-Hodgkin lymphoma has come back or stopped responding to at least two prior therapies. It aims to find out if AZD4512 can help when standard options are limited.
Irvine, CaliforniaAges 18 years+
NCT05332054Enrolling by invitation
Long-term follow-up after prior Caribou treatment
This study checks your health over time after you previously took a Caribou medicine (or got it through a special access program). It helps researchers learn what happens in the longer run after the treatment.
La Jolla, CaliforniaAges 18 years+

Refractory B-Cell Non-Hodgkin Lymphoma trials by city in California

Where these studies are running in California

Institutions with a site for the recruiting refractory b-cell non-hodgkin lymphoma studies listed above.

Providence Medical Foundation
Research Site
Stanford University
University of California Davis Comprehensive Cancer Center
University of California Los Angeles
University of California San Diego Health
University of California, Irvine

What taking part in a refractory b-cell non-hodgkin lymphoma study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Refractory B-Cell Non-Hodgkin Lymphoma trials in other states

Common questions

Are there refractory b-cell non-hodgkin lymphoma clinical trials in California?: Yes. We're currently tracking 28 recruiting refractory b-cell non-hodgkin lymphoma studies with a site in California, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a refractory b-cell non-hodgkin lymphoma study in California?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in California to take part?: Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a refractory b-cell non-hodgkin lymphoma trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New refractory b-cell non-hodgkin lymphoma studies open in California regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.